Neurology Inpatient Clinical Education Trial

Neurology Inpatient Clinical Education Trial

Sponsors

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Source Dartmouth-Hitchcock Medical Center
Brief Summary

The objective of this study is to compare the effectiveness of a personalized patient education program to the current hospital education and evaluate its impact using patient satisfaction scores.

The investigators hypothesize that a personalized patient education intervention will increase patient's understanding of their diagnosis and satisfaction with the care as reflected in the survey results.

Overall Status Active, not recruiting
Start Date February 1, 2019
Completion Date December 27, 2020
Primary Completion Date October 31, 2020
Phase N/A
Study Type Interventional
Primary Outcome
Measure Time Frame
Patient satisfaction scores Subjects will be expected to mail the feedback forms within 2 weeks of discharge. Investigators will mail a single reminder prepaid return mail with a copy of the questionnaire to patients who do not respond within this time allowing 1 month total time.
Enrollment 80
Condition
Intervention

Intervention Type: Behavioral

Intervention Name: Current standard discharge educational intervention

Description: The patients will receive the current hospital standard discharge educational material which explains the diagnosis, new medications, follow up and any activity/diet restrictions. A member of the study team will explain this material to the patient and answer any questions.

Arm Group Label: Current standard education group

Intervention Type: Behavioral

Intervention Name: Personalized discharge educational intervention

Description: The patients will receive a new personalized discharge educational material which will explain the specifics of their disorder, the treatment, and prognosis. The materials will contain simple, organized explanations and graphics. A member of the study team will explain this material to the patient and answer any questions.

Arm Group Label: New personalized education group

Eligibility

Criteria:

Inclusion Criteria:

- Over the age of 18

- Must have the capacity to consent and understand the study related activities and education materials.

Exclusion Criteria:

- Under the age of 18

- Have a condition that impairs the ability to understand the study, its risks, and appropriately consent for the study

Gender: All

Minimum Age: 18 Years

Maximum Age: 95 Years

Healthy Volunteers: No

Overall Official
Last Name Role Affiliation
Vijay Renga, MD Principal Investigator Dartmouth-Hitchcock Medical Center
Location
Facility: Dartmouth- Hitchcock Medical Center
Location Countries

United States

Verification Date

April 2020

Responsible Party

Type: Principal Investigator

Investigator Affiliation: Dartmouth-Hitchcock Medical Center

Investigator Full Name: Vijay Renga

Investigator Title: Principal Investigator

Keywords
Has Expanded Access No
Condition Browse
Number Of Arms 2
Arm Group

Label: Current standard education group

Type: Active Comparator

Description: A study team member will use the current hospital standard educational material to explain the discharge diagnosis to the patient, the treatment, and the follow up needed. The study team member will also give a survey with a preaddressed envelope to each participant to complete at his or her convenience.

Label: New personalized education group

Type: Experimental

Description: A study team member will use the new personalized educational materials to explain the discharge diagnosis to the patient, the treatment, and the follow up needed. The study team member will also give a survey with a preaddressed envelope to each participant to complete at his or her convenience.

Patient Data No
Study Design Info

Allocation: Randomized

Intervention Model: Parallel Assignment

Intervention Model Description: Study team members will randomize patients to receive either the current standard hospital education material or the new personalized education material. Investigators will use a stratified randomization process to allocate the patients from different categories including age range, gender, and discharge diagnosis into each group. Thereby the investigators will achieve equal distribution of diagnoses and other demographics among groups in real time. They will review the two groups when performing statistical analysis near the end of the study to ensure heterogeneity of distribution. A study team member who has also been a member of the care team will use the either the current hospital standard or the new personalized education materials to explain the discharge diagnosis to the patient, the treatment, and the follow up needed. The study team member will also give a survey with a preaddressed envelope to each participant to complete at his or her convenience.

Primary Purpose: Health Services Research

Masking: Single (Participant)

Masking Description: The patient will not be informed of whether he or she is receiving the current hospital standard or the new personalized patient education intervention. The study team member will known which intervention is being used for patient education. The intervention arm will not be blinded in the data analysis.

Source: ClinicalTrials.gov